|
SLC35A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.99489999999481E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.523700E-03 |
| Normal-vs-Stage2 |
2.038400E-03 |
| Normal-vs-Stage3 |
6.34319999970323E-07 |
| Normal-vs-Stage4 |
1.8741799999944E-05 |
| Stage1-vs-Stage2 |
4.043600E-01 |
| Stage1-vs-Stage3 |
2.776300E-03 |
| Stage1-vs-Stage4 |
4.180400E-02 |
| Stage2-vs-Stage3 |
2.046400E-01 |
| Stage2-vs-Stage4 |
3.402800E-01 |
| Stage3-vs-Stage4 |
7.980600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.81830000000249E-05 |
| Normal-vs-AfricanAmerican |
1.5725399999944E-05 |
| Normal-vs-Asian |
2.076000E-01 |
| Caucasian-vs-AfricanAmerican |
6.002200E-02 |
| Caucasian-vs-Asian |
1.605600E-02 |
| AfricanAmerican-vs-Asian |
1.144670E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.481150E-03 |
| Normal-vs-Female |
3.92719999999791E-05 |
| Male-vs-Female |
3.910200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.620700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.72399999999584E-05 |
| Normal-vs-Age(61-80Yrs) |
2.17380000000489E-07 |
| Normal-vs-Age(81-100Yrs) |
1.073840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.064000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.678700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.462400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.575620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.782200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.623400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.089750E-02 |
| Classical-VS-Follicular |
1.495150E-01 |
| Classical-VS-Other |
4.233000E-01 |
| Classical-VS-Normal |
1.322980E-03 |
| Tall-VS-Follicular |
1.122600E-01 |
| Tall-VS-Other |
1.482630E-01 |
| Tall-VS-Normal |
1.57073000000008E-05 |
| Follicular-VS-Other |
2.558400E-01 |
| Follicular-VS-Normal |
4.025700E-04 |
| Other-VS-Normal |
6.220200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.85180000000474E-05 |
| Normal-vs-N1 |
5.463700E-03 |
| N0-vs-N1 |
6.816200E-01 |
|
|
